Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
In need of quick funds? Discover ways to get cash instantly from bank services to meet your urgent needs.
21,071 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Cursor, valued near $29 billion, stands at the center of a fast-moving AI coding boom. The company faces intense grow...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
IGIC's Q1 2026 results highlight growth momentum alongside margin pressure. This article breaks down the igic 2026 ea...
When a board member sells shares, investors watch closely. This article unpacks a recent Arteris insider move, what i...
Netflix reports revenue growth driven by ads and a leaner strategy, while Disney posts margins and park revenue gains...
SanDisk is leading a powerful memory-chip rally, jumping 558% this year as AI-driven data-center demand reshapes expe...
Publishers, printers, and retailers are adapting to inflation, backlogs, and shifting demand as the journey from prop...
U.S. farmers confront renewed uncertainty as a China summit closes without a clear deal, while Iran's conflict drives...
NextEra Energy announces a $67 billion all-stock deal to buy Dominion Energy, a move that could kick off a broader wa...
As inflation cools, a 65-year-old with $7,000 a month must navigate taxes, geography, and housing to determine if ret...